These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 32104702)

  • 1. Analysis of the Expression of
    Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
    Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the
    Chen C; Chen S; Luo M; Yan H; Pang L; Zhu C; Tan W; Zhao Q; Lai J; Li H
    Ann Transl Med; 2020 Mar; 8(5):190. PubMed ID: 32309337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer.
    Gu P; Yang D; Zhu J; Zhang M; He X
    Medicine (Baltimore); 2022 Feb; 101(5):e28788. PubMed ID: 35119046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.
    Sun CC; Zhou Q; Hu W; Li SJ; Zhang F; Chen ZL; Li G; Bi ZY; Bi YY; Gong FY; Bo T; Yuan ZP; Hu WD; Zhan BT; Zhang Q; Tang QZ; Li DJ
    Aging (Albany NY); 2018 May; 10(5):973-987. PubMed ID: 29754146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the correlation between the expression of WFDC2 in B cells of lung adenocarcinoma tissue and the survival rate of patients].
    Zhang H; Lu J; Yang Y; Wang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 May; 35(5):425-433. PubMed ID: 31223112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer.
    Li Z; Liu Z; Li C; Liu Q; Tan B; Liu Y; Zhang Y; Li Y
    Transl Cancer Res; 2021 Jul; 10(7):3404-3417. PubMed ID: 35116645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cell divisioncycle-associated genes and their prognostic significance in hepatocellular carcinoma.
    Wang Z; Xu J; Zhang S; Chang L
    Int J Clin Exp Pathol; 2021; 14(2):151-169. PubMed ID: 33564348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.
    Zeng Y; Li N; Liu W; Zeng M; Cheng J; Huang J
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2447-2460. PubMed ID: 32627077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma.
    Cheng C; Ai Z; Zhao L
    Genes Genomics; 2020 Jul; 42(7):779-789. PubMed ID: 32462520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.
    Bai Y; Qiao L; Xie N; Shi Y; Liu N; Wang J
    PLoS One; 2017; 12(9):e0184902. PubMed ID: 28922388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic and prognostic analysis of the IL‑17 family genes in lung cancer.
    Liao T; Fan J; Lv Z; Xu J; Wu F; Yang G; Huang Q; Guo M; Hu G; Zhou M; Duan L; Wang S; Jin Y
    Mol Med Rep; 2019 Jun; 19(6):4906-4918. PubMed ID: 31059089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of the cell division cycle-associated gene family in hepatocellular carcinoma.
    Tao Q; Chen S; Liu J; Zhao P; Jiang L; Tu X; Tang X; Liu Z; Yasheng A; Tuerxun K; Zheng Y
    J Gastrointest Oncol; 2021 Apr; 12(2):781-794. PubMed ID: 34012666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of inhibitor of differentiation/DNA-binding gene family in lung cancer using bioinformatics methods.
    Xu S; Wang Y; Li Y; Zhang L; Wang C; Wu X
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32003423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining.
    Chen Y; Tian D; Chen X; Tang Z; Li K; Huang Z; Fu Y; Feng Y; Yang Z
    Int J Gen Med; 2021; 14():967-981. PubMed ID: 33790626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.
    Wang Z; Chen S; Wang G; Li S; Qin X
    Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of PLKs expression and prognosis in breast cancer.
    Jiawei W; Xiajun B; Tian S; Xuzheng G; Zhenwang Z
    Cancer Genet; 2022 Nov; 268-269():83-92. PubMed ID: 36206661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient.
    Phan NN; Wang CY; Li KL; Chen CF; Chiao CC; Yu HG; Huang PL; Lin YC
    Oncotarget; 2018 Jan; 9(6):6977-6992. PubMed ID: 29467944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
    Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
    Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
    Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
    Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Li D; Chen B; Zeng Y; Wang H
    Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.